The National Health Insurance Administration (NHIA) plans to set up a specialized office to speed up the process of adding new drugs to National Health Insurance (NHI) coverage, administration Director-General Shih Chung-liang (石崇良) said yesterday.
As new drugs are being developed that are relatively expensive, several medical welfare groups and patients’ associations, including the Formosa Cancer Foundation and Taiwan Young Patient Association, have urged the government to set up a special fund to help cover medical expenses for the new drugs and speed up the NHI coverage review process.
The groups have said it takes about two years for new cancer drugs to be assessed and included in the list of drugs covered by the NHI.
Photo: CNA
New drugs currently need to pass a review and obtain a drug license from the Food and Drug Administration (FDA) before applying to the administration for NHI coverage.
Shi said the specialized office would speed up the review of new drugs — especially those for unmet medical needs, breakthrough therapies, or which have a longer-lasting effect and can replace current drugs.
Hopefully the office would start operating in January next year, he said, adding that its main functions would be to conduct health technology assessments of new drugs, gather clinical data on new drugs that are temporarily covered by the NHI for future assessment, database management and training personnel to assist drug companies in providing the correct information in their report.
The proposed budget for the office is NT$100 million (US$3.14 million) for the first year, and the number of office personnel would be expanded from eight administrative personnel at present to about 100, including specialists in health economics, statistics and database management, Shi said.
With the FDA and the office reviewing the drugs simultaneously, the goal is to reduce the process to one year, he said.
As the office would be handling sensitive personal information when gathering clinical data, the next phase should be to establish an administrative agency, similar to the British National Institute for Health and Care Excellence, but legislation would be required for that, which would take about three to four years, Shi said,
As the UK has the Cancer Drugs Fund and the Innovative Medicines Fund, which provide interim funding for patients to gain access to promising new drugs faster, the administration also hopes to set up a new fund for drugs that is separate from the NHI global budget, Shi said
He said about 80 percent of the new drugs funded by the Innovative Medicines Fund later passed review and were covered by the British National Health Service, so the new drugs fund could cover new drugs where some uncertainties remain regarding their therapeutic effects, and further data and assessment is required.
The first global hotel Keys Selection by the Michelin Guide includes four hotels in Taiwan, Michelin announced yesterday. All four received the “Michelin One Key,” indicating guests are to experience a “very special stay” at any of the locations as the establishments are “a true gem with personality. Service always goes the extra mile, and the hotel provides much more than others in its price range.” Of the four hotels, three are located in Taipei and one in Taichung. In Taipei, the One Key accolades were awarded to the Capella Taipei, Kimpton Da An Taipei and Mandarin Oriental Taipei. Capella Taipei was described by
The Taichung District Court yesterday confirmed its final ruling that the marriage between teenage heir Lai (賴) and a man surnamed Hsia (夏) was legally invalid, preventing Hsia from inheriting Lai’s NT$500 million (US$16.37 million) estate. The court confirmed that Hsia chose not to appeal the civil judgement after the court handed down its ruling in June, making the decision final. In the June ruling, the court said that Lai, 18, and Hsia, 26, showed “no mutual admiration before the marriage” and that their interactions were “distant and unfamiliar.” The judge concluded that the couple lacked the “true intention of
EVA Airways today confirmed the death of a flight attendant on Saturday upon their return to Taiwan and said an internal investigation has been launched, as criticism mounted over a social media post accusing the airline of failing to offer sufficient employee protections. According to the post, the flight attendant complained of feeling sick on board a flight, but was unable to take sick leave or access medical care. The crew member allegedly did not receive assistance from the chief purser, who failed to heed their requests for medical attention or call an ambulance once the flight landed, the post said. As sick
INDUSTRY: Beijing’s latest export measures go beyond targeting the US and would likely affect any country that uses Chinese rare earths or related tech, an academic said Taiwanese industries could face significant disruption from China’s newly tightened export controls on rare earth elements, as much of Taiwan’s supply indirectly depends on Chinese materials processed in Japan, a local expert said yesterday. Kristy Hsu (徐遵慈), director of the Taiwan ASEAN Studies Center at the Chung-Hua Institution for Economic Research, said that China’s latest export measures go far beyond targeting the US and would likely affect any country that uses Chinese rare earths or related technologies. With Japan and Southeast Asian countries among those expected to be hit, Taiwan could feel the impact through its reliance on Japanese-made semi-finished products and
RSS